Webinar: The Pathway to Driving Valuation for Your Laboratory: Your Roadmap to Achieving Success, and How to Sustain Growth Despite a Changing Lab Environment

Why is it so vital for your lab to understand and maximize its value, even if you’re not in a buying or selling mode? Regardless of whether your lab is in a buying or selling mode—or just preparing for what the future may hold—this timely webinar will provide you with the essential insights you need to increase revenue and operating margin, and effectively maximize your laboratory’s value.

In this webinar, attendees will learn:

  • Understand the market factors that are creating serious financial challenges for your laboratory
  • Strategies you can implement now to significantly improve your market position
  • Learn the most important key performance indicators (KPIs) to ensure your lab’s success
  • Why optimizing reimbursements, not cost-cutting, is one of most successful ways to improve financial performance
  • Learn the steps your lab needs to take to optimize its reimbursements
  • Why it is crucial for your CFO to be fully engaged when it comes to monitoring reimbursement metrics and trends
  • Why compliance is so important to laboratory valuation, plus the components of an effective compliance program
  • The importance of revenue cycle management (RCM) as a valuation driver
  • Current trends in valuation and merger and acquisition activity and how to prepare for the future
  • Appreciate the specific challenges that should be addressed in any merger or consolidation plan, and much more!

Featured XIFIN Speaker

Vicki DiFrancesco, Chief Strategy Officer, XIFIN, Inc.

Vicki DiFrancesco is the Chief Strategy Officer at XIFIN. Vicki is an accomplished diagnostics executive with more than 25 years in executive leadership positions, most recently serving as president and CEO of Pathology Inc., the west coast's premier women’s health laboratory that was acquired by LabCorp in March 2016. Previously, she served as senior vice president, sales and marketing for Specialty Laboratories Inc.; executive vice president of sales and marketing for Spectrum Laboratory Network; and vice president of hospital sales and marketing at Quest Diagnostics, Inc. She has also held executive level positions with American Medical Laboratories and Laboratory Corporation of America. Vicki currently serves on the Board of Directors of PWNHealth, LLC. She holds a BS degree in biological sciences from California State University, Sacramento.

Additional Speaker

David Nichols, MBA, Founder, Nichols Management Group

Since founding NMG, Mr. Nichols has been fundamental in identifying, negotiating and closing eleven acquisitions worth over $900 million, and launching three start-ups worth $475 million.  Mr. Nichols’ previous experience includes serving as Director of Worldwide Business Planning for Allergan Pharmaceutical, a division of SmithKline Beecham, and as Director of Physician Marketing and Managed Care for SmithKline Beecham Clinical Laboratories.  He also served as a Market Research Analyst and Senior Sales Representative at MetPath Laboratories. Mr. Nichols received his MBA from Cornell University and was awarded the Sloan Certificate in Hospital Administration while at Cornell.  He also studied Labor Relations at the University of Bath (England) and received his BBA from the University of Miami.


Richard Faherty, Managing Director, The Dark Intelligence Group, Inc.

Richard Faherty is currently consulting primarily with laboratory services.  He was the Executive Vice President, Administration, for BioReference Laboratories (BRLI) until his retirement in July 2017.  He spent more than 20 years at BRLI overseeing general corporate affairs as well as all technology; he was President of PSIMedica (the Company’s clinical knowledge management division) and the creator of CareEvolve, the Company’s connectivity solution up until its recent sale to ELLKAY.  Prior to BRLI, Faherty worked in financial technology at S&P Comstock and A-T Financial Services, as well as a Y2K project manager for MetLife. He has been associated with the clinical laboratory business since 1986 when he began consulting for GenCare Biomedical (later acquired by BioReference). Faherty is a graduate of the University of Notre Dame and Fordham Law School. After practicing law for nearly ten years, he became involved in Information Technology and has been involved with complex data management, networking solutions, and application and data distribution since that time.

DARK Daily is a concise e-news/management briefing on timely topics in clinical laboratory and anatomic pathology group management. It is a solution to the dilemma facing anyone in the laboratory profession.


The Pathway to Driving Valuation for Your Laboratory: Your Roadmap to Achieving Success, and How to Sustain Growth Despite a Changing Lab Environment
The Pathway to Driving Valuation for Your Laboratory: Your Roadmap to Achieving Success, and How to Sustain Growth Despite a Changing Lab Environment